RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. Show More...
-
Website https://renovorx.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.40 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 2021-12 TTM Earnings Per Share USD -0.46 -0.45 -1.21 -0.91 Dividends USD Payout Ratio % * Shares Mil 8.0 8.0 5.0 9.0 Book Value Per Share * USD 1.96 1.38 Free Cash Flow Per Share * USD -0.49 Return on Assets % -169.12 -181.55 -69.49 -107.45 Financial Leverage (Average) 1.06 1.11 Return on Equity % Return on Invested Capital % Interest Coverage -5.44 Current Ratio 2.81 0.47 17.36 9.92 Quick Ratio 2.61 0.44 16.2 9.33 Debt/Equity